Deep learning based low-activity PET reconstruction of [11C]PiB and [18F]FE-PE2I in neurodegenerative disorders

被引:11
|
作者
Daveau, Raphael Sura [1 ]
Law, Ian [1 ]
Henriksen, Otto Molby [1 ]
Hasselbalch, Steen Gregers [2 ]
Andersen, Ulrik Bjorn [1 ]
Anderberg, Lasse [1 ]
Hojgaard, Liselotte [1 ]
Andersen, Flemming Littrup [1 ]
Ladefoged, Claes Nohr [1 ]
机构
[1] Univ Copenhagen, Dept Clin Physiol & Nucl Med, Rigshosp, Copenhagen, Denmark
[2] Univ Copenhagen, Danish Dementia Res Ctr, Rigshosp, Copenhagen, Denmark
关键词
Parkinson's disease; F-18]FE-PE2I; Alzheimer's disease; C-11]PiB; Deep learning; PET denoising; DOPAMINE TRANSPORTER; DISEASE; CRITERIA;
D O I
10.1016/j.neuroimage.2022.119412
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Purpose: Positron Emission Tomography (PET) can support a diagnosis of neurodegenerative disorder by identifying disease-specific pathologies. Our aim was to investigate the feasibility of using activity reduction in clinical [F-18]FE-PE2I and [C-11]PiB PET/CT scans, simulating low injected activity or scanning time reduction, in combination with AI-assisted denoising. Methods: A total of 162 patients with clinically uncertain Alzheimer's disease underwent amyloid [C-11]PiB PET/CT and 509 patients referred for clinically uncertain Parkinson's disease underwent dopamine transporter (DAT) [F-18]FE-PE2I PET/CT. Simulated low-activity data were obtained by random sampling of 5% of the events from the list-mode file and a 5% time window extraction in the middle of the scan. A three-dimensional convolutional neural network (CNN) was trained to denoise the resulting PET images for each disease cohort. Results: Noise reduction of low-activity PET images was successful for both cohorts using 5% of the original activity with improvement in visual quality and all similarity metrics with respect to the ground-truth images. Clinically relevant metrics extracted from the low-activity images deviated < 2% compared to ground-truth values, which were not significantly changed when extracting the metrics from the denoised images. Conclusion: The presented models were based on the same network architecture and proved to be a robust tool for denoising brain PET images with two widely different tracer distributions (delocalized, ([C-11]PiB, and highly localized, [F-18]FE-PE2I). This broad and robust application makes the presented network a good choice for improving the quality of brain images to the level of the standard-activity images without degrading clinical metric extraction. This will allow for reduced dose or scan time in PET/CT to be implemented clinically.
引用
收藏
页数:9
相关论文
共 50 条
  • [1] Reproducibility of PET studies with L-[β-11C]DOPA and [18F]FE-PE2I in healthy humans
    Suzuki, Masayuki
    Ito, Hiroshi
    Takano, Harumasa
    Fujiwara, Hironobu
    Kimura, Yasuyuki
    Kodaka, Fumitoshi
    Varrene, Andrea
    Okubo, Yoshiro
    Suhara, Tetsuya
    JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2012, 32 : S131 - S131
  • [2] Blood Flow Dependence of Early [11C]PE2I and [18F]FE-PE2I PET SUVR Measurements Used In the Differential Diagnosis of Parkinsonian Disorders
    Jonasson, M.
    Langaas, G.
    Appel, L.
    Danfors, T.
    Fazio, P.
    Lubberink, M.
    Varrone, A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 45 : S303 - S304
  • [3] Stability of [18F]FE-PE2I
    Denholt, Charlotte
    Lehel, Szabolcs
    Madsen, Jacob
    Gillings, Nic
    JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2019, 62 : S325 - S326
  • [4] Reproducibility of PET measurement for presynaptic dopaminergic functions using L-[β-11C]DOPA and [18F]FE-PE2I in humans
    Suzuki, Masayuki
    Ito, Hiroshi
    Kodaka, Fumitoshi
    Takano, Harumasa
    Kimura, Yasuyuki
    Fujiwara, Hironobu
    Sasaki, Takeshi
    Takahata, Keisuke
    Nogami, Tsuyoshi
    Nagashima, Tomohisa
    Nengaki, Nobuki
    Kawamura, Kazunori
    Zhang, Ming-Rong
    Varrone, Andrea
    Halldin, Christer
    Okubo, Yoshiro
    Suhara, Tetsuya
    NUCLEAR MEDICINE COMMUNICATIONS, 2014, 35 (03) : 231 - 237
  • [5] Striatal dopamine transporter and receptor availability correlate with relative cerebral blood flow measured with [11C]PE2I, [18F]FE-PE2I and [11C]raclopride PET in healthy individuals
    Jonasson, My
    Frick, Andreas
    Fazio, Patrik
    Hjorth, Olof
    Danfors, Torsten
    Axelsson, Jan
    Appel, Lieuwe
    Furmark, Tomas
    Varrone, Andrea
    Lubberink, Mark
    JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2023, 43 (07): : 1206 - 1215
  • [6] Striatal dopamine transporter availability and D2 receptor density correlate to relative blood flow measured with [11C]PE2I, [18F]FE-PE2I and [11C]raclopride PET
    Jonasson, M.
    Fazio, P.
    Frick, A.
    Appel, L.
    Laurell, G. L.
    Danfors, T.
    Fredrikson, M.
    Furmark, T.
    Varrone, A.
    Lubberink, M.
    JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2019, 39 : 544 - 544
  • [7] Sertraline treatment influences [18F]FE-PE2I PET imaging for Parkinsonism
    Thomas E. H. Justesen
    Per Borghammer
    Joel Aanerud
    Peter Hovind
    Lisbeth Marner
    EJNMMI Research, 13
  • [8] Feasibility of dose reduction in [18F]-FE-PE2I PET in DAT imaging
    Lehnskov, T.
    Riisberg, D.
    Marner, L.
    Lonsdale, M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2021, 48 (SUPPL 1) : S214 - S214
  • [9] Sertraline treatment influences [18F]FE-PE2I PET imaging for Parkinsonism
    Justesen, Thomas E. H.
    Borghammer, Per
    Aanerud, Joel
    Hovind, Peter
    Marner, Lisbeth
    EJNMMI RESEARCH, 2023, 13 (01)
  • [10] Kinetic Analysis and Quantification of the Dopamine Transporter in the Non-Human Primate Brain with [11C]PE2I and [18F]FE-PE2I
    Varrone, A.
    Steiger, C.
    Toth, M.
    Takano, A.
    Guilloteau, D.
    Gulyas, B.
    Halldin, C.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2009, 36 : S223 - S223